Winocour, P H <br/><br/>
Double-blind placebo-controlled study of the effects of bezafibrate on blood lipids, lipoproteins, and fibrinogen in hyperlipidaemic type 1 diabetes mellitus.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association   
 - 736-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0742-3071 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-5491.1990.tb01479.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Bezafibrate--therapeutic use<br/>Blood Glucose--metabolism<br/>Diabetes Mellitus, Type 1--blood<br/>Double-Blind Method<br/>Fibrinogen--drug effects<br/>Humans<br/>Hyperlipidemias--drug therapy<br/>Lipids--blood<br/>Lipoproteins--drug effects<br/>Middle Aged